Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-κB down-modulation

Dong Wook Han, Hye Ryeon Lim, Hyun Sook Baek, Mi Hee Lee, Seung Jin Lee, Suong Hyu Hyon, Jong Chul Park

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The abnormal growth of vascular smooth muscle cells (VSMCs) plays an important role in vascular diseases, including atherosclerosis and restenosis after angioplasty. Although (-)-epigallocatechin-3-O-gallate (EGCG) has antiproliferative effects on various cells, relatively a little is known about precise mechanisms of the inhibitory effects of EGCG on SMCs. In this study, the inhibitory effects of EGCG on attachment, proliferation, migration, and cell cycle of rat aortic SMCs (RASMCs) with serum stimulation were investigated. Also, the involvement of nuclear factor-κB (NF-κB) during these inhibitions by EGCG was examined. EGCG treatment resulted in significant (p < 0.05) inhibition in attachment and proliferation of RASMCs induced by serum. While non-treated RASMCs migrated into denuded area in response to serum and showed essentially complete closure after 36 h, EGCG-treated cells covered only 31% of the area even after 48 h of incubation. Furthermore, EGCG treatment resulted in an appreciable cell cycle arrest at both G0/G1- and G2/M-phases. The immunoblot analysis revealed that the constitutive expression of NF-κB/p65 nuclear protein in RASMCs was lowered by EGCG in both the cytosol and the nucleus in a dose-dependent manner. These results suggest that the EGCG-caused inhibitory effects on RASMCs may be mediated through NF-κB down-modulation.

Original languageEnglish
Pages (from-to)148-155
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume345
Issue number1
DOIs
Publication statusPublished - 2006 Jun 23

Fingerprint

Smooth Muscle Myocytes
Muscle
Rats
Cells
Modulation
Serum
epigallocatechin gallate
G2 Phase
Nuclear Proteins
Cell Cycle Checkpoints
Vascular Diseases
Vascular Smooth Muscle
Angioplasty
Cell Division
Cytosol
Atherosclerosis
Cell Cycle
Therapeutics
Growth

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Han, Dong Wook ; Lim, Hye Ryeon ; Baek, Hyun Sook ; Lee, Mi Hee ; Lee, Seung Jin ; Hyon, Suong Hyu ; Park, Jong Chul. / Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-κB down-modulation. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 345, No. 1. pp. 148-155.
@article{5ae1427679ba4b02b9d5ebbd21ccfa97,
title = "Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-κB down-modulation",
abstract = "The abnormal growth of vascular smooth muscle cells (VSMCs) plays an important role in vascular diseases, including atherosclerosis and restenosis after angioplasty. Although (-)-epigallocatechin-3-O-gallate (EGCG) has antiproliferative effects on various cells, relatively a little is known about precise mechanisms of the inhibitory effects of EGCG on SMCs. In this study, the inhibitory effects of EGCG on attachment, proliferation, migration, and cell cycle of rat aortic SMCs (RASMCs) with serum stimulation were investigated. Also, the involvement of nuclear factor-κB (NF-κB) during these inhibitions by EGCG was examined. EGCG treatment resulted in significant (p < 0.05) inhibition in attachment and proliferation of RASMCs induced by serum. While non-treated RASMCs migrated into denuded area in response to serum and showed essentially complete closure after 36 h, EGCG-treated cells covered only 31{\%} of the area even after 48 h of incubation. Furthermore, EGCG treatment resulted in an appreciable cell cycle arrest at both G0/G1- and G2/M-phases. The immunoblot analysis revealed that the constitutive expression of NF-κB/p65 nuclear protein in RASMCs was lowered by EGCG in both the cytosol and the nucleus in a dose-dependent manner. These results suggest that the EGCG-caused inhibitory effects on RASMCs may be mediated through NF-κB down-modulation.",
author = "Han, {Dong Wook} and Lim, {Hye Ryeon} and Baek, {Hyun Sook} and Lee, {Mi Hee} and Lee, {Seung Jin} and Hyon, {Suong Hyu} and Park, {Jong Chul}",
year = "2006",
month = "6",
day = "23",
doi = "10.1016/j.bbrc.2006.04.072",
language = "English",
volume = "345",
pages = "148--155",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-κB down-modulation. / Han, Dong Wook; Lim, Hye Ryeon; Baek, Hyun Sook; Lee, Mi Hee; Lee, Seung Jin; Hyon, Suong Hyu; Park, Jong Chul.

In: Biochemical and Biophysical Research Communications, Vol. 345, No. 1, 23.06.2006, p. 148-155.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-κB down-modulation

AU - Han, Dong Wook

AU - Lim, Hye Ryeon

AU - Baek, Hyun Sook

AU - Lee, Mi Hee

AU - Lee, Seung Jin

AU - Hyon, Suong Hyu

AU - Park, Jong Chul

PY - 2006/6/23

Y1 - 2006/6/23

N2 - The abnormal growth of vascular smooth muscle cells (VSMCs) plays an important role in vascular diseases, including atherosclerosis and restenosis after angioplasty. Although (-)-epigallocatechin-3-O-gallate (EGCG) has antiproliferative effects on various cells, relatively a little is known about precise mechanisms of the inhibitory effects of EGCG on SMCs. In this study, the inhibitory effects of EGCG on attachment, proliferation, migration, and cell cycle of rat aortic SMCs (RASMCs) with serum stimulation were investigated. Also, the involvement of nuclear factor-κB (NF-κB) during these inhibitions by EGCG was examined. EGCG treatment resulted in significant (p < 0.05) inhibition in attachment and proliferation of RASMCs induced by serum. While non-treated RASMCs migrated into denuded area in response to serum and showed essentially complete closure after 36 h, EGCG-treated cells covered only 31% of the area even after 48 h of incubation. Furthermore, EGCG treatment resulted in an appreciable cell cycle arrest at both G0/G1- and G2/M-phases. The immunoblot analysis revealed that the constitutive expression of NF-κB/p65 nuclear protein in RASMCs was lowered by EGCG in both the cytosol and the nucleus in a dose-dependent manner. These results suggest that the EGCG-caused inhibitory effects on RASMCs may be mediated through NF-κB down-modulation.

AB - The abnormal growth of vascular smooth muscle cells (VSMCs) plays an important role in vascular diseases, including atherosclerosis and restenosis after angioplasty. Although (-)-epigallocatechin-3-O-gallate (EGCG) has antiproliferative effects on various cells, relatively a little is known about precise mechanisms of the inhibitory effects of EGCG on SMCs. In this study, the inhibitory effects of EGCG on attachment, proliferation, migration, and cell cycle of rat aortic SMCs (RASMCs) with serum stimulation were investigated. Also, the involvement of nuclear factor-κB (NF-κB) during these inhibitions by EGCG was examined. EGCG treatment resulted in significant (p < 0.05) inhibition in attachment and proliferation of RASMCs induced by serum. While non-treated RASMCs migrated into denuded area in response to serum and showed essentially complete closure after 36 h, EGCG-treated cells covered only 31% of the area even after 48 h of incubation. Furthermore, EGCG treatment resulted in an appreciable cell cycle arrest at both G0/G1- and G2/M-phases. The immunoblot analysis revealed that the constitutive expression of NF-κB/p65 nuclear protein in RASMCs was lowered by EGCG in both the cytosol and the nucleus in a dose-dependent manner. These results suggest that the EGCG-caused inhibitory effects on RASMCs may be mediated through NF-κB down-modulation.

UR - http://www.scopus.com/inward/record.url?scp=33646401565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646401565&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.04.072

DO - 10.1016/j.bbrc.2006.04.072

M3 - Article

C2 - 16677605

AN - SCOPUS:33646401565

VL - 345

SP - 148

EP - 155

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -